Download PDF
Thromb Haemost 2012; 107(06): 1189-1191
DOI: 10.1160/TH11-11-0788
Letters to the Editor
Schattauer GmbH

Dabigatran etexilate (Pradaxa®) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiency

Cedric Hermans
1   Hemostasis and Thrombosis Unit, Division of Adult Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
,
Stéphane Eeckhoudt
2   Hemostasis and Thrombosis Laboratory, Division of Biological Chemistry, Cliniques Universitaires Saint-Luc, Brussels, Belgium
,
Catherine Lambert
1   Hemostasis and Thrombosis Unit, Division of Adult Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
› Author Affiliations
Further Information

Publication History

Received: 14 November 2011

Accepted after major revision: 21 February 2012

Publication Date:
29 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Ward CT, Chavalitanonda N. Atypical warfarin-induced skin necrosis. Pharmacotherapy 2006; 26: 1175-1179.
    CrossrefPubMedGoogle Scholar
  • 2 AdEl DD, Meirovitz A, Weinberg A. et al. Warfarin skin necrosis: local and systemic factors. Br J Plast Surg 2000; 53: 624-626.
    CrossrefPubMedGoogle Scholar
  • 3 Nazarian RM, Van Cott EM, Zembowicz A. et al. Warfarin-induced skin necrosis. J Am Acad Dermatol 2009; 61: 325-332.
    CrossrefPubMedGoogle Scholar
  • 4 Gelwix TJ, Beeson MS. Warfarin-induced skin necrosis. Am J Emerg Med 1998; 16: 541-543.
    PubMedGoogle Scholar
  • 5 Stewart AJ, Penman ID, Cook MK. et al. Warfarin-induced skin necrosis. Postgrad Med J 1999; 75: 233-235.
    CrossrefPubMedGoogle Scholar
  • 6 Essex DW, Wynn SS, Jin DK. Late-onset warfarin-induced skin necrosis: case report and review of the literature. Am J Hematol 1998; 57: 233-237.
    CrossrefPubMedGoogle Scholar
  • 7 Cole MS, Minifee PK, Wolma FJ. Coumarin necrosis--a review of the literature. Surgery 1988; 103: 271-277.
    PubMedGoogle Scholar
  • 8 Sorensen DM, Eilbert W. Images in emergency medicine. Man with painful skin lesion. Warfarin sodium skin necrosis. Ann Emerg Med 2010; 55: 302-305.
    CrossrefPubMedGoogle Scholar
  • 9 Perzborn E, Roehrig S, Straub A. et al. The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor. Nat Rev Drug Discov 2011; 10: 61-75.
    CrossrefPubMedGoogle Scholar
  • 10 Hankey GJ, Eikelboom JW. Dabigatran etexilate: a new oral thrombin inhibitor. Circulation 2011; 123: 1436-1450.
    CrossrefPubMedGoogle Scholar